AVENUE THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Avenue Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Avenue Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.6M, a 24.7% increase year-over-year.
  • Avenue Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$11.3M, a 22.4% increase year-over-year.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$11.3M, a 22.4% increase from 2023.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$14.5M, a 80.8% decline from 2022.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$8.04M, a 115% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.3M +$3.26M +22.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$14.5M -$6.5M -80.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$8.04M -$4.31M -115% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$3.74M +$1.48M +28.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$5.21M +$21.1M +80.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 -$26.3M -$4.45M -20.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$21.8M -$10.4M -91% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$11.4M -$9.04M -380% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$2.38M +$2.47M +50.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 -$4.84M Feb 9, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.